Abstract Long-term survival after childhood cancer has improved dramatically over recent decades but survivors face lifelong risks of adverse health effects. Many of these chronic conditions are a direct result of previous therapeutic exposures. Compared to their siblings, survivors face a greater than 8-fold increase in relative risk of severe or life-threatening medical conditions; the most significant of these include second malignancies and cardiovascular and pulmonary diseases. Imaging can play a key role in identifying and characterizing such complications, which can be reasonably predicted with knowledge of the child's treatment. This article highlights the varied radiologic presentations and features seen in late cancer-therapy-related conditions.
Introduction
Long-term survival after childhood cancer has improved dramatically over recent decades, with 5-year survival rates ranging from 64% to 97% [1] compared to 45% in the mid-1970s [2] . Despite such encouraging statistics, survivors face an increased lifelong risk of adverse health effects [3, 4] , many of which stem directly from their previous therapeutic exposures [5] . Results from the Childhood Cancer Survivor Study (CCSS) have shown that compared with their siblings, survivors face an 8.2-fold increased relative risk for a severe or lifethreatening condition, with cumulative incidence of chronic conditions reaching 73.4% at 30 years after diagnosis [6] .
The late effects can affect all organ systems (Table 1) , but the most severe conditions include second malignancies and cardiovascular and pulmonary diseases [7] [8] [9] [10] . The Children's Oncology Group (COG) has developed risk-based, exposure-related guidelines for follow-up care in childhood cancer survivors [11] . Radiology plays a key role in both identifying and characterizing complications, most of which can be reasonably predicted with knowledge of the type of treatment received [12] .
This article serves as a companion piece to our review on acute and subacute toxicities of cancer therapies in children [13] . This article highlights the radiologic appearances of late cancer-therapy-related, non-neurological conditions, defined as those occurring at least 1 year after the conclusion of therapy. Some complications, although not strictly diagnosed by imaging, are also described for their secondary radiologic features. Table 1 provides a general overview of the various organ systems involved, and the more commonly seen entities are described in further detail in this article.
Multisystem complications Chronic graft-versus-host disease
Allogenic hematopoietic stem cell transplantation (HSCT) is a well-established treatment for some hematologic malignancies [14] . The incidence of chronic graft-versus-host disease (GVHD) following HSCT in children ranges from 6% when the stem cells are infused from a matched sibling to 65% when they are provided by a matched unrelated donor [15] . Chronic GVHD is no longer defined based on the time after HSCT (historically, >100 days after transplantation), but according to specific clinical and functional criteria that suggest immune dysfunction, none of which relies upon imaging features [16] . The median onset of chronic GVHD after HSCT is approximately 6 months and onset is usually not seen after 3 years post-transplantation [16] . Acute GVHD typically involves skin, liver and gastrointestinal tract. However, chronic GVHD can involve any organ system. Imaging manifestations of chronic GVHD include gastrointestinal strictures, findings that mimic primary sclerosing cholangitis (PSC) and bronchiolitis obliterans [17] . Although PSC-like changes have been described in experimental chronic GVHD in a mice model [18] , this has not been reported in children (Fig. 1) . It is estimated that 80% of people with chronic GVHD have liver involvement [19] and if a biopsy is required to confirm diagnosis, an interventional radiologist might be asked for assistance.
Second malignant neoplasms
Second malignant neoplasms are defined as "histologically distinct malignancies developing after completion of treatment for the primary malignancy" [20] . They are the most Leg-length discrepancy, soft-tissue hypoplasia, slipped capital femoral epiphyses, pathological fractures from reduced bone mineral density, radiation osteitis, short stature, scoliosis, osteochondroma formation, poor dental enamel and root formation (associated with radiation therapy, or chemotherapy with methotrexate and corticosteroids)
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frequent cause for non-relapse late mortality in survivors [21] , who have a 3-to 6-fold increased risk of malignancy compared to the general population [22] . The risk of developing a second malignant neoplasm has been estimated to be 10% at 20 years and 26% at 30 years age [23] , although this risk varies with the type of primary cancer diagnosis (there is a higher risk in hereditary retinoblastoma [24] and Hodgkin lymphoma survivors [25] ), therapy received and underlying genetic predisposition (e.g., LiFraumeni syndrome).
Post-treatment solid tumors are more strongly associated with radiation therapy, whereas those associated with chemotherapy (typically alkylating agents or topoisomerase II inhibitors) include myelodysplasia and acute myeloid leukemia [26] . Solid second malignant neoplasms include breast (the most common second malignant neoplasm in the CCSS cohort [27] ), thyroid, brain and bone tumors [22] (Fig. 2) . In general, the higher the radiation dose received and the younger the age at treatment, the greater the risk for developing solid second malignant neoplasms.
Imaging is used for surveillance in selected subgroups such as those with a cancer predisposition syndrome [28] . Whole- Fig. 1 Chronic graft-versus-host disease (GVHD) with liver involvement in a 7-year-old boy post hematopoietic stem cell transplantation for acute lymphoblastic leukemia. a, b Axial T2-W MR images of the liver demonstrate increased periportal signal (a, arrows) and dilatation of extrahepatic bile duct (b, arrowhead). c High-resolution US image of the porta hepatis demonstrates common bile duct (arrowhead) with wall thickening and luminal dilatation (calipers). Findings of increased periportal signal, duct dilatation and duct wall thickening seen in this child with biopsy-proven chronic GVHD resemble those seen in primary sclerosing cholangitis body MRI is a radiation-free technique to screen for these neoplasms. Periodic whole-body MRI might be performed in children with Li-Fraumeni syndrome for development of any neoplasm because they are predisposed to cancer development [28] . Girls who get chest radiation are at increased risk for subsequent breast cancer. The Children's Oncology Group recommends initiation of screening MRI/mammography at age 25 or 8 years after radiation, whichever is later [12] .
Endocrine dysfunction Thyroid
The thyroid gland may be included within the radiation field when treating head and neck tumors, or during cranio-spinal irradiation. Hypothyroidism is the most common thyroid disorder following radiotherapy [29] and can also occur after HSCT [30] . However, even when this condition is present, the thyroid gland can still look normal on sonography. Histopathological changes of an irradiated thyroid gland include follicular degeneration, stromal atrophy and obliteration of underlying vasculature [31] . Sonographic features of the irradiated thyroid gland can include diffuse atrophy, solitary or multiple nodules (which may be malignant), cysts (simple and complex) and heterogeneity within the thyroid tissue [32] (Fig. 3) . Differentiating malignant from benign nodules sonographically can be difficult, but features concerning for malignancy include the presence of microcalcifications and irregular margins, and absence of a uniform hypoechoic halo around the nodule [33] . Even though a hypoechoic halo has 95% specificity for a benign thyroid nodule, a halo is not seen in >50% of benign nodules [33] . Also, 10-24% of papillary thyroid carcinomas have either a complete or incomplete halo around them [33] .
Growth
Cranial irradiation can damage the hypothalamic-pituitary axis, leading to gonadotropin or growth hormone deficiency at high dosages, and precocious puberty at lower dosages [34] [35] [36] [37] . The age of pubertal onset has been shown to be particularly important in determining final height, with younger children being at greater risk of developing precocious puberty and therefore eventual shorter stature [38] . Growth hormone deficiency can be seen in children who received total body irradiation in preparation for bone marrow transplantation [39] . The radiologist might be asked to review a child's bone age to determine the degree of bone delay or advancement. Knowledge of this late effect can also be helpful to the radiologist reviewing a skeletal survey for short stature.
Pulmonary complications
Significant long-term pulmonary dysfunction, as determined by pulmonary function tests (PFT), can be seen in survivors after therapy [40, 41] . These effects are more likely to occur if children receive both chemotherapy and radiation, and can be seen in up to 72% of cases [26] . Pulmonary late effects include pulmonary fibrosis, interstitial pneumonitis, and restrictive/ obstructive lung diseases. In children surviving 5 years or more, the Childhood Cancer Survivor Studies [42] found a significant association between cancer therapy and lung fibrosis, recurrent pneumonia and pleurisy. The strongest association of pulmonary damage was demonstrated between radiotherapy and pulmonary fibrosis. However, pulmonary toxic chemotherapy agents such as bleomycin, busulfan, lomustine (CCNU [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea]) and carmustine (BCNU [bis-chloroethylnitrosourea]) also contributed to developing fibrosis. Chest CT is useful for detecting pulmonary fibrosis, bronchiolitis obliterans and bronchiolitis obliterans organizing pneumonia (BOOP). Pulmonary fibrosis involves the part of the lung included in the radiation field (Fig. 4) . Typical fibrotic changes can be seen in the medial aspects of both lungs in Hodgkin lymphoma survivors who received mediastinal radiation. Non-pulmonary findings, such as simple thymic cysts, can also occur as a result of chemotherapy or radiation. If large, these can mimic tumor recurrence [43] . 
Cardiovascular complications
Congestive cardiac failure and cardiomyopathy are wellrecognized complications from prior anthracycline chemotherapy or chest radiation [44] . This is of particular concern because approximately 60% of survivors might have been exposed to one of these therapies [10] . They face a 15-fold increased risk of heart failure [6] compared to the general population. The condition is progressive and can be clinically silent for years [45] . For this reason several oncology groups worldwide advocate lifelong screening with echocardiography and clinical assessment every 1-5 years, depending on cumulative anthracycline dose exposure, radiation to a field that included the heart, and age at therapy [46] . Chest radiographs might demonstrate cardiomegaly with or without signs of cardiac failure (Fig. 5) , but the imaging modality of choice for screening for cardiomyopathy is echocardiogram. 
Gastrointestinal complications Enteric
Chronic radiation enteropathy typically occurs 6-24 months post radiotherapy [31] . It can manifest as mucosal ulceration, stricture formation, malabsorption or bowel obstruction [47] (Fig. 6) ; the last is reported to occur in 36% of survivors [48] .
Surgical intervention for the primary malignancy can also result in subsequent adhesion formation. If resection of previously irradiated bowel is later needed, there is a high incidence of anastomotic dehiscence, re-obstruction and even mortality [49] .
Esophageal strictures (Fig. 7) and acquired tracheoesophageal fistulas can also be seen in children treated with radiation or chemotherapy [50] . However, these are rare and more commonly associated with non-malignant causes, like foreign body ingestion, severe mucositis and candida esophagitis [51, 52] .
Hepatobiliary

Focal nodular hyperplasia
Focal nodular hyperplasia (FNH) is a non-malignant entity seen with increasing frequency in children following treatment with chemotherapy, HSCT or radiation [53] [54] [55] . The interval between cancer diagnosis and discovery of FNH ranges 2-12 years with median interval of 6.7 years [56] . A liver lesion might initially be identified on sonography but FNH can be diagnosed with greater confidence and accuracy by liver MRI [57] (Fig. 8) . FNH in cancer survivors tends to be multiple, small (<3 cm) and atypical, with lack of a central scar. The use of MRI with hepatocyte-specific contrast media like gadobenate helps to differentiate FNH from metastases [58] .
Hemochromatosis
Iron overload is common in cancer survivors who have received multiple red blood cell transfusions and is associated with hepatic, cardiac and endocrine dysfunction. Siderosis can be histologically identified in up to 70% of children near the end of their treatment for acute lymphoblastic leukemia [59] [60] [61] , and hepatic iron overload can be reliably diagnosed and approximately quantified by MRI [62] [63] [64] (Fig. 9) . 
Hepatosteatosis
Fatty infiltration of the liver can occur for several reasons in childhood cancer survivors, such as from immunosuppressive chemotherapeutic agents; in survivors of hepatoblastoma treated with liver transplantation [65] , or as part of a metabolic syndrome in cancer survivors secondary to late effects of hyperlipidemia, insulin resistance from total whole-body irradiation, and bone marrow transplantation [66] . Fatty infiltration results in increased echogenicity of the hepatic parenchyma on sonography. Fatty infiltration can be reliably diagnosed with inand out-phase imaging on MRI.
Hepatobiliary toxicity
Limited data exist on late effects of chemotherapy on the liver but hepatobiliary dysfunction is thought to be related to prior antimetabolite agent therapy (e.g., methotrexate, 6-mercaptopurine) and after HSCT [67] . Delayed hepatic injury might not be preceded by clinically apparent acute toxicity before leading to hepatic fibrosis. Fibrosis places the child at risk of developing portal hypertension, cirrhosis and hepatocellular carcinoma [68] . Radiation-induced hepatic damage is uncommon in cancer survivors unless predisposing conditions (e.g., viral hepatitis, iron overload) are present [69] . In our experience, nonspecific increased echogenicity and heterogeneity of hepatic parenchyma are commonly observed on US in cancer survivors, which could represent some form of hepatic damage.
Genitourinary system complications
Therapy-related late effects on kidneys include radiation nephropathy, renal atrophy (with focal or diffuse parenchymal and functional loss [70] ; Fig. 10 ) and end-stage renal disease (ESRD) as a result of radiation or nephrotoxic chemotherapeutic agents (such as cisplatin [71] and ifosfamide [72] ). These toxicities are generally observed 6 months or more after treatment [73] .
Bladder fibrosis can develop from radiotherapy or chemotherapy (particularly cyclophosphamide), resulting in Fig. 9 Iron deposition in a 12-year-old boy with disseminated pineoblastoma and hepatic metastases (arrows) as seen on (a) out-phase short echo time (TE) MRI and (b) in-phase long TE MRI. Compared to the out-phase image with short TE (a) the liver and spleen lose signal on in-phase MR image with longer TE (b), suggestive of siderosis Fig. 10 Marked renal atrophy in a 10-year-old boy who was diagnosed at 2 years of age with right adrenal neuroblastoma and was treated with surgery, chemotherapy and radiotherapy. a Coronal reformatted postintravenous-contrast CT image demonstrates a small right kidney (arrow) with cortical thinning and loss of parenchymal volume. The kidney was normal at the time of tumor diagnosis. b Nuclear medicine study, posterior projection, to assess the boy's glomerular filtration rate demonstrates total loss of function in the right kidney (arrow) interstitial fibrosis of the bladder wall. Urgency and frequency from reduced bladder capacity are common symptoms. Imaging, though rarely used to make the diagnosis, might demonstrate a contracted and poorly distensible bladder, sometimes accompanied by hydronephrosis [74] . Fistula formation to adjacent bowel loops rarely occurs in children but is more common in adults after brachytherapy [70] .
Gonadal dysfunction is the most severe long-term effect in cancer survivors, especially after alkylating agents and pelvic radiotherapy [64] . Hypothalamic-pituitary axis disorders also result in impaired fertility in cancer survivors [10, 75, 76] . Ovarian transposition outside the radiation field, usually superiorly in the abdomen, is sometimes performed prior to radiotherapy to minimize radiation damage to the ovaries in children with pelvic cancers [77] (Fig. 11) .
Musculoskeletal complications Bone growth deformity
Radiotherapy, chemotherapy and surgery have all been associated with long-term musculoskeletal effects independently and additively [78] . Radiation therapy can affect chondroblast and chondrocyte proliferation with reduction in bone growth; soft-tissue hypoplasia can also result. Scoliosis is thought to be sometimes caused by radiation-induced asymmetrical growth plate impairment (Fig. 12) . Chances of spinal malalignment increase with younger age at exposure, higher doses, and asymmetrical radiation [78] . Bony hypoplasia, especially involving flat bones, can result from inhibition of osteogenesis by radiation [78] . Severe facial deformity has been noted in up to 30% of children who received radiation for head and neck rhabdomyosarcoma [79] . Growth disturbances affecting hips and pelvis include hemiatrophy of the pelvis (Fig. 13) , slipped capital epiphyses (Fig. 14) and osteonecrosis of the femoral head. Other effects include leg-length discrepancy and muscular atrophy [78, 80, 81] . Radiographs play an important role in assessment of these abnormalities related to bone growth and could be sufficient in most cases.
Bone mineral density changes
Treatment with corticosteroids, methotrexate and radiotherapy has been implicated in altered bone remodeling [82] and reduction in bone mineral density, predisposing patients to pathological fractures [30] (Fig. 15) . The incidence of bone mineral density deficits may be as high as 45% in cancer survivors [83] .
Radiation osteitis is typically witnessed 1 year after therapy [81] and can be difficult to differentiate from residual or metastatic bone disease. As irradiated bone heals, osteoid deposits can form, resulting in a coarsened trabecular matrix pattern with disorganized sclerosis (Fig. 16) .
Bone tumors
Osteochondromas are the most common secondary bone tumor to develop within a radiation field. Their incidence is 1-2% in the general population but 6-20% in children treated with radiation therapy (Figs. 17 and 18) . The propensity for malignant degeneration is rare and not thought to be greater than that in the general population [84, 85] .
Radiation-induced bone sarcomas, in particular osteosarcomas, can develop in cancer survivors [86] . The risk increases significantly in children with cancer predisposition syndromes such as retinoblastoma and Li-Fraumeni syndrome. The mean Fig. 16 Radiation osteitis in a 14-year-old boy who had previous radiotherapy for Ewing sarcoma centered within the right inferior pubic ramus bone (arrows). a, b Anteroposterior pelvic radiographs taken during the primary diagnosis at 8 years of age (a) and at age of 14 years (b) demonstrate progressive right iliac atrophy, heterogeneous sclerosis at the right acetabulum, shortened right femoral neck and loss of height of the right proximal femoral epiphysis. c Coronal CT with bone windows obtained at age 13 years better demonstrates the bony changes in the right acetabulum and proximal femur (arrow) Fig. 17 A small osteochondroma in an 8-year-old girl previously treated with craniospinal irradiation for medulloblastoma. a Axial CT with softtissue windows demonstrates a small osseous lesion (arrow) extending into the spinal canal at the T7-8 level, with mass effect on the thecal sac, although not causing any spinal cord compression. b T1-W fat-saturated post-contrast axial MR image at the same vertebral level reveals rim enhancement of the lesion (arrow) in keeping with the cartilaginous cap of the osteochondroma latency period for developing malignant bone tumors is about 10 years [87] . The presence of an enhancing soft-tissue mass associated with bone destruction seen on MRI helps to differentiate second malignancy bone sarcoma from radiation changes and infections.
Other effects
Methotrexate-induced osteopathy radiographically appears very similar to scurvy, with osteoporosis, decreased mineralization and fractures [88] . Dense metaphyseal bands of long bones, within epiphyseal ossification centers, anterior rib ends, sternum and spine have been reported in children receiving pamidronate for bone pain in metastatic osteosarcoma [89] .
Conclusion
The late effects of cancer therapy in children can affect all organ systems of the body and can cause early mortality. This article has highlighted many of the long-term sequelae that can be evaluated by imaging. With increase in long-term survival rates of childhood cancer patients, recognition of these radiologic findings is of vital importance to both pediatric and adult radiologists. 
